ZNF697 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.696800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.733800E-01
Normal-vs-Stage2
6.996400E-01
Normal-vs-Stage3
7.041600E-01
Normal-vs-Stage4
9.253200E-01
Stage1-vs-Stage2
5.035400E-01
Stage1-vs-Stage3
8.603200E-01
Stage1-vs-Stage4
2.823400E-01
Stage2-vs-Stage3
6.653200E-01
Stage2-vs-Stage4
5.121600E-01
Stage3-vs-Stage4
3.781400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.943200E-01
Normal-vs-AfricanAmerican
9.386800E-01
Normal-vs-Asian
3.809200E-01
Caucasian-vs-AfricanAmerican
6.823400E-01
Caucasian-vs-Asian
2.728400E-01
AfricanAmerican-vs-Asian
1.972610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.591800E-01
Normal-vs-Female
7.996800E-01
Male-vs-Female
5.744800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.900200E-01
Normal-vs-Age(41-60Yrs)
8.894000E-01
Normal-vs-Age(61-80Yrs)
6.994000E-01
Normal-vs-Age(81-100Yrs)
6.809800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.178000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.593200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.543600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.094000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.841040E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.044800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.264400E-01
Normal-vs-Daily Drinker
6.239000E-01
Normal-vs-Weekly Drinker
9.140000E-01
Normal-vs-Occasional Drinker
7.078000E-01
Normal-vs-Social Drinker
9.539000E-01
Non Drinker-vs-Daily Drinker
3.904200E-01
Non Drinker-vs-Weekly Drinker
2.334000E-01
Non Drinker-vs-Occasional Drinker
5.942800E-01
Non Drinker-vs-Social Drinker
4.057400E-01
Daily Drinker-vs-Weekly Drinker
7.339900E-02
Daily Drinker-vs-Occasional Drinker
2.709000E-01
Daily Drinker-vs-Social Drinker
2.653400E-01
Weekly Drinker-vs-Occasional Drinker
6.615200E-01
Weekly Drinker-vs-Social Drinker
7.333600E-01
Occasional Drinker-vs-Social Drinker
5.715400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.982000E-01
Normal-vs-Grade 2
3.347600E-01
Normal-vs-Grade 3
4.222200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.162200E-02
Grade 1-vs-Grade 3
3.093600E-02
Grade 1-vs-Grade 4
6.982000E-01
Grade 2-vs-Grade 3
4.370800E-01
Grade 2-vs-Grade 4
3.347600E-01
Grade 3-vs-Grade 4
4.222200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.512400E-01
Normal-vs-NonDiabetic
7.562600E-01
Diabetic-vs-NonDiabetic
4.452000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.973400E-01
Normal-vs-NoPancreatitis
6.617200E-01
Pancreatitis-vs-NoPancreatitis
3.783800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.252200E-01
Normal-vs-N1
8.335400E-01
N0-vs-N1
8.261400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.707400E-01
Normal-vs-TP53-NonMutant
3.503000E-01
TP53-Mutant-vs-TP53-NonMutant
3.898800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
